curacle co.,ltd. (KOSDAQ:365270)
South Korea · Delayed Price · Currency is KRW 9,650.00
-300.00 (-3.02%)
At close: Sep 3, 2026
curacle co.,ltd. Market Cap
curacle co.,ltd. has a market cap or net worth of 214.11 billion as of September 4, 2026. Its market cap has increased by 307.01% in one year.
Market Cap
214.11B
Enterprise Value
202.25B
Revenue
8.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,650.00
ChartMarket Cap Chart
Since July 22, 2021, curacle co.,ltd.'s market cap has decreased from 409.36B to 214.11B, a decrease of -47.70%. That is a compound annual growth rate of -11.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 214.11B | 42.93% |
| Dec 30, 2025 | 149.80B | 79.35% |
| Dec 30, 2024 | 83.52B | -48.17% |
| Dec 28, 2023 | 161.14B | 2.54% |
| Dec 29, 2022 | 157.15B | -49.31% |
| Dec 30, 2021 | 310.02B | -24.27% |
| Jul 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HansBiomed | 275.67B |
| IntoCell | 273.25B |
| S.Biomedics | 231.35B |
| Kanaph Therapeutics | 214.94B |
| IMBiologics | 211.99B |
| Kangstem Biotech | 205.04B |
| Genome & Company | 175.20B |
| NIBEC | 171.65B |